Jessica ConstantAssociate Director - Commercial Excellence - Oncology at AstraZenecaSpeaker
Agenda Sessions
Beyond Compliance Monitoring: Implementing a Robust Three Lines of Defense Strategy for Speaker Programs
, 1:00pmView Session
